STERO Biotechs
STERO Ltd., founded in 2017 and headquartered in Israel, is a clinical-stage company committed to the research and development of novel and improved Cannabidiol (CBD) based treatment solutions that will potentially benefit millions of patients by reducing the side effects and the need of steroid therapy.
Biotechnology
About STERO Biotechs
STERO’s patent was granted! In the US on August 2018. Stero’s 1st Phase IIa clinical trial stared on May 2019 on AutoImmune Hepatitis (AIH), a 2nd Phase IIa clinical trial in Crhon’s disease (IBD) on June 2019 and more indication in the pipeline for 2019.
Contact info
Phone:
(972) 3 617-6173
Address:
Barukh Hirsch St 14, Bnei Brak, Israel
